It was observed in COVID-19 patients that plasminogen activator inhibitor-1 (PAI-1), vitronectin, plasminogen, and tPA were elevated and fibrin clots formed from COVID-19 patient plasma showed altered fibrin network structures with elevated cross-linking and shorter fibrin fibres [164]. This evidence concerns the gene SERPINE1 and COVID-19.